Efficacy and Safety of Neoadjuvant Luteinizing Hormone-Releasing Hormone Antagonist and Tegafur-Uracil Chemohormonal Therapy for High-Risk Prostate Cancer

Background: This retrospective single-center cohort study evaluated the efficacy and safety of a combination of neoadjuvant luteinizing hormone-releasing hormone (LHRH) antagonist and tegafur-uracil (UFT) therapy (NCHT) and investigated the medical records of patients with high-risk PCa who underwen...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugino, Fumiya, Nakane, Keita, Kawase, Makoto, Ueda, Shota, Tomioka, Masayuki, Takeuchi, Yasumichi, Tomioka-Inagawa, Risa, Yamada, Toyohiro, Namiki, Sanae, Kumada, Naotaka, Takeuchi, Shinichi, Kawase, Kota, Kato, Daiki, Takai, Manabu, Iinuma, Koji, Tobisawa, Yuki, Koie, Takuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223720/
https://www.ncbi.nlm.nih.gov/pubmed/37240717
http://dx.doi.org/10.3390/life13051072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223720/
https://www.ncbi.nlm.nih.gov/pubmed/37240717
http://dx.doi.org/10.3390/life13051072

Ejemplares similares